Who owns PTCT?
Institutional ownership of PTC Therapeutics Inc. from Form 13F, Q2 2026
382 institutional managers reported holding PTC Therapeutics Inc. (PTCT) in Form 13F filings for Q2 2026, with 100,329,115 shares worth $8.2B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 4,771,906 shares (+5.4%). 73 opened new positions and 44 sold out.
- Funds holding
- 382
- Value held
- $8.2B
- New / sold out
- 73 / 44
- Net shares, same filers
- +5.4%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of PTCT
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| BlackRock, Inc. | $1.1B | 13.9% | 13,964,554 | Added |
| RTW Investments, LP | $632M | 7.7% | 7,746,415 | Unchanged |
| Jupiter Topco LLC | $590M | 7.2% | 7,236,402 | First report |
| Vanguard Portfolio Management LLC | $402M | 4.9% | 4,928,111 | Added |
| State Street Corp | $375M | 4.6% | 4,598,952 | Added |
| Wellington Management Group LLP | $337M | 4.1% | 4,128,273 | Added |
| Vanguard Capital Management LLC | $305M | 3.7% | 3,739,127 | Added |
| Geode Capital Management, LLC | $180M | 2.2% | 2,207,376 | Trimmed |
| Toronto Dominion Bank | $177M | 2.2% | 2,165,846 | Trimmed |
| Westfield Capital Management Co LP | $160M | 1.9% | 1,956,156 | New |
| Hood River Capital Management LLC | $142M | 1.7% | 1,738,613 | Added |
| William Blair Investment Management, LLC | $141M | 1.7% | 1,722,688 | New |
| D. E. Shaw & Co., Inc. | $126M | 1.5% | 1,548,919 | Trimmed |
| Tang Capital Management LLC | $122M | 1.5% | 1,500,000 | Unchanged |
| Bank of America Corp | $118M | 1.4% | 1,452,277 | Trimmed |
| Driehaus Capital Management LLC | $117M | 1.4% | 1,440,107 | Added |
| FMR LLC | $114M | 1.4% | 1,398,261 | Trimmed |
| Jefferies Financial Group Inc. | $111M | 1.4% | 1,357,042 | Added |
| Fuller & Thaler Asset Management, Inc. | $94.4M | 1.2% | 1,156,819 | New |
| Pictet Asset Management Holding SA | $93.6M | 1.1% | 1,147,844 | Trimmed |
| Price T Rowe Associates Inc | $90.9M | 1.1% | 1,114,516 | Added |
| Morgan Stanley | $90.0M | 1.1% | 1,103,675 | Added |
| Armistice Capital, LLC | $87.4M | 1.1% | 1,071,395 | Trimmed |
| Blue Sparrow, LLC | $85.7M | 1.0% | 1,050,700 | Added |
| Franklin Resources Inc | $83.8M | 1.0% | 1,027,327 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 100,329,115 PTCT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Westfield Capital Management Co LP New+$160M
- William Blair Investment Management, LLC New+$141M
- Fuller & Thaler Asset Management, Inc. New+$94.4M
- BlackRock, Inc. Added+$82.9M
- Blue Sparrow, LLC Added+$70.2M
- Price T Rowe Associates Inc Added+$52.2M
- Arrowstreet Capital, Limited Partnership Added+$44.3M
- American Century Companies Inc Added+$40.5M
- Morgan Stanley Added+$35.0M
- Driehaus Capital Management LLC Added+$34.6M
Biggest sellers in Q2 2026
- UBS Group AG Trimmed-$89.9M
- Armistice Capital, LLC Trimmed-$81.8M
- Toronto Dominion Bank Trimmed-$70.2M
- Woodline Partners LP Sold out-$50.8M
- BNP Paribas Financial Markets Trimmed-$44.2M
- Balyasny Asset Management L.P. Trimmed-$35.9M
- Bank of America Corp Trimmed-$35.4M
- Mackenzie Financial Corp Trimmed-$25.6M
- SG Americas Securities, LLC Trimmed-$22.4M
- Panagora Asset Management Inc Trimmed-$21.4M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $1.1B and sold $737M; 140 added and 112 trimmed.
Schedule 13D and 13G filings on PTCT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-16WELLINGTON MANAGEMENT GROUP LLP SCHEDULE 13G filed by PTC Therapeutics Inc.Schedule 13G
- 2026-11-10STATE STREET CORP SCHEDULE 13G filed by PTC Therapeutics Inc.Schedule 13G
- 2026-02-17JANUS HENDERSON GROUP PLC SCHEDULE 13G filed by Janus Henderson Group plcSchedule 13G
- 2026-02-13TORONTO DOMINION BANK SCHEDULE 13G filed by PTC Therapeutics Inc.Schedule 13G
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by PTC Therapeutics Inc.Schedule 13G
Questions about PTCT ownership
- Who owns PTCT stock?
- 382 institutional investment managers reported PTCT positions in their Form 13F filings for Q2 2026, holding 100,329,115 shares worth $8.2B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling PTCT?
- In Q2 2026, 73 managers opened new PTCT positions, 140 added, 112 trimmed and 44 sold out. Managers that filed in both quarters added a net 4,771,906 shares.
- How current is this PTCT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to PTCT by CUSIP. Options are left out. PTCT news and filings · PTCT insider trades · Top funds